|
|
Efficacy of fosinopril on proteinuria in children with Henoch-Schonlein purpura nephritis |
XU Jian, CONG Hui, SHENG Yu |
Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China |
|
Cite this article: |
XU Jian,CONG Hui,SHENG Yu. Efficacy of fosinopril on proteinuria in children with Henoch-Schonlein purpura nephritis[J]. 中国当代儿科杂志, 2009, 11(03): 229-230.
|
|
|
|
XU Jian,CONG Hui,SHENG Yu. Efficacy of fosinopril on proteinuria in children with Henoch-Schonlein purpura nephritis[J]. CJCP, 2009, 11(03): 229-230.
|
URL: |
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2009/V11/I03/229 |
| [1]Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, OrmalaT, et al. Outcome of Henoch-Schonlein nephritis with nephriticrange proteinuria[J]. Clin Nephrol, 2003, 60(2): 80-84.
|
| [2]Sundel R, Szer I. Vasculitis in childhood[J]. Rheum Dis Clin Am, 2002, 28(3): 625-654.
|
| [3]周玲,陈钟,贾劬.小儿紫癜性肾炎的临床病理及远期预后分析[J].中国当代儿科杂志,2001,3(2):139-140.
|
| [4]姜红,李维,张良.尿5项蛋白在过敏性紫癜肾炎诊断中的价值[J].中国当代儿科杂志,2004,6(4):300-302.
|
| [5]黄文彦,陈荣华,甘卫华,丁桔霞,黄松明,姜新猷.儿童过敏性紫癜临床特征分析[J].中国当代儿科杂志,2002,4(3):183-185.
|
| [6]《血管紧张素转换酶抑制剂在肾脏病中的正确应用》专家协作组.血管紧张素转换酶抑制剂在肾脏病中正确应用的专家共识[J].中华肾脏病杂志, 2006, 22(1): 57-58.
|
| [7]林瑞青,杨青,庄捷秋,杨宇真,陈敏广.贝那普利对小儿IgA肾病尿蛋白的作用[J] .中华肾脏病杂志, 2007, 23(5):299-301.
|
| [8]江文益.福辛普利加大剂量治疗慢性肾脏病蛋白尿及高血压的疗效观察[J] .海南医学, 2007, 18(1):11-12.
|
| [9]Li JS, Berezny K, Kilaru R, Hazan L, Portman R, Hogg R, et al. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children? [J]. Hypertension, 2004, 44(3):289-293.
|
| [10]陈崴,赖德源,傅慧芳,孔耀中,刘岩,傅君舟,等.增大剂量的福辛普利治疗慢性肾脏病轻中度蛋白尿的前瞻性研究[J].中华肾脏病杂志, 2005, 1(21): 9-12.
|
| [11]吴玉斌.过敏性紫癜性肾炎的治疗进展[J].中国实用儿科杂志, 2006, 6(21):411-413.
|
| [12]杨华彬,易著文.小儿紫癜性肾炎的药物治疗进展[J].实用药物与临床, 2005, 1(18):12-14.
|
| [13]Graciano ML, Cavaglieri Rde C, Dellê H, Dominguez WV, Casarini DE, Malheiros DM,et al.Intrarenal Rennin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis[J]. J Am Soc Nephrol, 2004, 15(7):1805-1815.
|
| [14]Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies[J]. N Engl J Med, 1998, 339(20):1448-1456.
|
| [15]刘必成,李敏侠.肾素血管紧张素系统阻断剂的肾保护作用[J] .中华肾脏病杂志, 2007, 2(23):129-132.
|
[1] |
GUO Hong-Xiang, ZHANG Jian-Jiang, SHI Pei-Pei, FU Shu-Qin, ZHANG Li-Guo, WANG Miao, LU Feng-Xia. A clinico-pathological comparison between Henoch-Schonlein purpura nephritis and IgA nephropathy in children[J]. 中国当代儿科杂志, 2012, 14(07): 506-509. |
[2] |
HUANG Dan-Lin, XU Zi-Chuan, DANG Xi-Qiang, ZENG Xue-Qi, HE Xiao-Jie, YI Zhu-Wen, HE Qing-Nan. Relationship between renal Th1/Th2 ratio and renal microvascular injury in children with Henoch-Schonlein purpura nephritis[J]. 中国当代儿科杂志, 2011, 13(4): 273-277. |
[3] |
ZHENG Wen-Jie, CHEN Min-Guang, CHEN Xiao-Ying, YANG Qing, LIN Rui-Xia. Renal expression of macrophage migration inhibitory factor in children with Henoch-Sch-nlein purpura nephritis[J]. 中国当代儿科杂志, 2010, 12(2): 120-122. |
[4] |
ZENG Xue-Qi, XU Zi-Chuan, DANG Xi-Qiang, HE Xiao-Jie, YI Zhu-Wen. Expression of vascular endothelial growth factor is related to microvessel injury of renal interstitium in children with Henoch Sch nlein purpura nephritis[J]. 中国当代儿科杂志, 2009, 11(9): 717-721. |
[5] |
ZHANG Gao-Ping, DANG Xi-Qiang, YI Zhu-Wen, HE Xiao-Jie, ZHANG Jian-Jiang, WU Xiao-Chuan, MO Shuang-Hong. Role of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schonlein purpura nephritis[J]. 中国当代儿科杂志, 2007, 9(2): 125-128. |
[6] |
ZHANG Guo-Zhen, WU Xiao-Chuan, YI Hong, PENG Xiao-Jie, DANG Xi-Qiang, HE Xiao-Jie, YI Zhu-Wen. Relationship between clinical manifestations and renal pathology in children with Henoch-Schonlein purpura nephritis[J]. 中国当代儿科杂志, 2007, 9(2): 129-132. |
[7] |
XU Jian, CONG Hui, SHENG Yu. Efficacy of fosinopril on proteinuria in children with Henoch-Schonlein purpura nephritis[J]. 中国当代儿科杂志, 2009, 11(03): 229-230. |
|
|
|
|